Propagation of large numbers of T cells with natural killer cell markers
- 1 July 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (3), 453-458
- https://doi.org/10.1111/j.1365-2141.1994.tb08297.x
Abstract
Summary. Previously, a subset of T cells co-expressing the NK cell antigen CD56 has been described. These CD3+CD56+ cells are rare in peripheral blood collections and have been poorly characterized. We have developed culture conditions which allow for the rapid expansion of CD3+CD56+ cells. The protocol for cellular expansion includes the addition of interferon-gamma on day O, interleukin-1, interleukin-2 and a monoclonal antibody against CD3 on day 1 to peripheral blood lymphocytes. Cells of the CD3+CD56+ phenotype increased up to 6000-fold using this protocol after 16 d in culture. These cells have been characterized by flow cytometry and have been found to express the alpha, beta T cell receptor, co-express the CD5 and CD8 antigens and do not express the CD16 antigen. Morphologically, these cells cannot be distinguished from NK cells. CD3+CD56+ killer cells lyse a variety of tumour cells with intermediate activity between CD3−CD56+ NK cells and CD3+CD56− T cells.Keywords
This publication has 14 references indexed in Scilit:
- Comparative studies of CD3− and CD3+ CD56+ cells: Examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expressionCellular Immunology, 1991
- Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.The Journal of Experimental Medicine, 1991
- Lymphokine-activated killer cell activity after cryopreservationJournal of Immunological Methods, 1989
- Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanomaInternational Journal of Cancer, 1988
- Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.The Journal of Immunology, 1987
- Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.The Journal of Experimental Medicine, 1986
- The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.The Journal of Immunology, 1986
- Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.The Journal of Immunology, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975